FDA Clearance Tracker · P130008-S092
SleepSync Programmer
Last checked: Nov 20, 2026Latest source record: Jun 27, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 27, 2023
Approved
Time to decision
225 days
Received Nov 14, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130008-S092
- Device name
- SleepSync Programmer
- Applicant
- Inspire Medical Systems
- Applicant location
- Maple Grove, MN
- Received
- Nov 14, 2022
- Decided
- Jun 27, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P130008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the updated SleepSync Programmer (Model 2740) which consists of the Inspire Programming Software Application (Model 2740S) that can be installed on customer owned devices and paired with the Inspire Programmer Cable (Model 2740C).
Source documents
Other decisions for Inspire Medical Systems
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Inspire Upper Airway Stimulation SystemPMA supplement
P130008-S090 · Decided Jun 8, 2023 · 234 days after receipt · Panel Track
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.